Funding for this research was provided by:
Received: 27 April 2020
Accepted: 30 July 2020
First Online: 25 August 2020
Ethics approval and consent to participate
: This prospective interventional study was carried out following the approval of the Research Ethical Committee of Faculty of Medicine, Tanta University, from November 2017 to September 2019, on fifty (50) patients age range 28–74 years with blood glucose levels below 150 mg/dL, histopathologically proven to have malignant melanoma. The reference number is “not applicable.”Informed written consent was obtained from all participants prior to use of PET/CT after full explanation of the benefits and risks of the procedure. This consent is “not applicable.”
: All patients included in this research gave written informed consent to publish the data contained within this study. If the patient was less than 16 years old, deceased, or unconscious when consent for publication was requested, written informed consent for the publication of this data was given by their parent or legal guardian. I accept and all authors to publish the paper.
: No conflict of interest.